Tu Vy Nguyen

Senior Manager, Clinical Operations Oncology at Quantum Leap Healthcare Collaborative

Tu Vy Nguyen has a diverse work experience in the healthcare and research field. Tu Vy started their most recent position as a Senior Manager of Clinical Operations Oncology at Quantum Leap Healthcare Collaborative in June 2021. Prior to that, they worked at the Harvard T.H. Chan School of Public Health Center for Executive and Continuing Professional Education as an Instructor Teaching Assistant from February 2018 to November 2021.

From June 2019 to June 2021, Tu Vy served as a Clinical Research Manager in Hematology Oncology at Stanford University School of Medicine. In this role, they managed a team of over 20 individuals conducting phase I-III clinical trials and successfully established Stanford's new Acute Myeloid Leukemia (AML) research program in 2019. Tu Vy also led the expansion of the Hematology Division's portfolio and CRG by 20%.

Before working at Stanford, Tu Vy held positions at the same institution, including Lead Clinical Research Coordinator from June 2018 to June 2019 and Clinical Research Coordinator II from August 2015 to June 2018.

Their earlier work experience includes working as a Clinical Research Coordinator at Clayton Eye Center from August 2013 to August 2015.

Throughout their career, Tu Vy has developed strong expertise in clinical operations, research management, and oncology.

Tu Vy Nguyen has a Certificate in Principals and Practice of Clinical Research from Harvard T.H. Chan School of Public Health, which they obtained in 2017. Tu Vy also has a Master of Science degree in Biomedical Sciences from Geisinger Commonwealth School of Medicine and a Bachelor of Science degree in Biomedical/Medical Engineering from Georgia Institute of Technology. Additionally, they hold a certification as a Certified Clinical Research Coordinator (CCRC) from the Association of Clinical Research Professionals, which they obtained in October 2016.

Links

Timeline

  • Senior Manager, Clinical Operations Oncology

    June, 2021 - present